The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MDS 2020 | MDS prognostic scores
Argiris Symeonidis
• 5 Mar 2020
Argiris Symeonidis, MD, PhD, University of Patras, Patras, Greece, discusses the prognostic scoring system and independent variables used to assess the severity of a patient’s myelodysplastic syndrome (MDS). He also highlights some of the specific comorbid conditions such as cardiovascular disease, which cause non-leukemic death. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.
